Overview
- 41 inspections across 41 sites are on record.
- 108 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-09-12.
At a glance
Inspections
41
Sites
41
Observations
108
Career since
Sep 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Meribel Pharma Pessac | 12 Sep 2019 | Human Drugs | |
| APL Strangnas AB | 6 Sep 2019 | Human Drugs | On file |
| NorthStar Medical Radioisotopes, LLC | 31 May 2019 | Human Drugs | On file |
| Aparna Pharmaceuticals Private Limited | 15 Mar 2019 | Human Drugs | On file |
| Sequent Research Limited | 26 Feb 2019 | Human Drugs |
Sites inspected
Meribel Pharma PessacPessac, France1 insp.
APL Strangnas ABStrangnas, Sweden1 insp.
NorthStar Medical Radioisotopes, LLCBeloit, United States1 insp.
Aparna Pharmaceuticals Private LimitedSrikakulam, India1 insp.
Sequent Research LimitedBengaluru, India1 insp.
Co-investigators
Investigators who share inspections with this person.
James K Ireland4 shared
Jamie L Dion4 shared
Haroon Vohra3 shared
Isabel Y Espinosa2 shared
Gerard T Schneider2 shared
Edith M Gonzalez2 shared
Zachary A Bogorad2 shared
Julia D Cartwright2 shared
Theressa B Smith2 shared
Jiao Yang1 shared
Full investigator report
Get the verbatim findings behind Tenzin Jangchup's 108 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site